In the interest of cost effectiveness, switching antiretroviral brand name medications to generics is recommended in France since The study objective was to evaluate the perception of generics per se and antiretroviral generics in HIV-infected patients and their hospital physicians. Patients completed a self-questionnaire on their perception and acceptability of generics.
Physicians completed a questionnaire on their acceptability of switching antiretroviral to generic. Socio-demographic data, medical history and HIV history were collected. No factor related to sociodemographic conditions, HIV status or comorbidities was associated with the acceptability of antiretroviral generics. It should be improved with an efficient information of both patients and physicians.
This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files. Mylan provided funding for data capture. Funding sources were not involved in study design, data collection, analysis, interpretation, medical writing or submission, decision to publish, or preparation of the manuscript.
Competing interests: The authors have the following interests: Mylan provided funding for data capture. There are no patents, products in development or marketed products to declare. In France, recurrent health expenditure amounted to billion Euros in , i.
